The Healthy Aging Company

DEVELOPING GAME CHANGER THERAPIES FOR
Diabetes Type 2 Diseases and its related complications such as Diabetic Neuropathy and Alzheimer's disease.

A Scientific Advisory Board with world renowned leaders in metabolism and diabetes

THAC set up a Strategic Advisory Board (SAB) composed of prominent figures from the academic world to expand its research and development strategic capabilities.
Members are internationally renowned scientific leaders in metabolism and diabetes, some being consultants for regulatory agencies (US FDA, EU EMA).
 
The THAC’s team is honored to benefit from their knowledge and fruitful expertise.

Advisory Board

Diabetic Neuropathy and Neurodegenerative Diseases

Dr. Solomon Tesfaye,
MB ChB, MD, FRCP


Research Director – Academic Directorate of Diabetes & Endocrinology
Sheffield Teaching Hospitals​

Dr. Didier Bouhassira,
MD, PhD


Inserm U-987
 Pathophysiology and Clinical Pharmacology of Pain 
Hôspital Ambroise Paré

Dr. Ralf Baron,
PhD, MD


Professor of Neurology at the CAU heads the Section for Neurological Ache Research and Therapy, Campus Kiel

Dr. Agnes Hartemann,
PhD, MD

Professor diabetologist CHU Pitié-Salpétrière Paris, Head of Diabetology Service
Expert diabetic wounds & feet

Dr. Kevin Nash,
PhD

Professor at University of South Florida.
Department of Molecular Pharmacology and Physiology

Diabetes

Pr. Bernard Thorens,
PhD

Professor UNIL Lausanne
University of biology and medicine
Head of CIG (center for Integrative Genomics)

Pr. Fabrizzio Andreelli,
MD, PhD

Professor diabetologist
CHU Pitie-Salpetriere Paris
Head of Department of Diabetology

Pr. Jean-François Gautier,
MD, PhD

Professor diabeto-endocrino-nutrition
CHU  Lariboisière, Paris
Head of Department of Diabetology

Pr. Robert Eckel, MD, PhD


Professor of Medecine Emeritus
University Cincinnati, USA
Endocrino-metabolism-diabetes
FDA Consultant

Pr. Stefano Del Prato,
MD, PhD

President EASD
Professor endocrinology and metabolism 
School of Medicine, University Pisa, Italy
Chief of section Diabetes

Advisors for Commercialization

Dr. Steven Currall,
PhD

Professor and Former President
 Muma College of Business
 University of South Florida
Research Associate
John A. Paulson School of Engineering and Applied Sciences
Harvard University

John Sinnott MD/FACP

Professor of Medicine
Department of Internal Medicine
Morsani College of Medicine
University of South Florida